Of note, although in a previous study [18] some clinical measures of disease severity were unaffected by this microsatellite polymorphism, MS patients with primary progressive disease course were found to have more commonly long AAT repeats, in line with the idea that neurodegenerative damage can be influenced in MS by CB1Rs [18]. The gene discussed is SERPINA1; the disease is myeloid sarcoma.